Former RQM+ CEO Margaret Keegan and CEO John Potthoff [Image courtesy of RQM+]
Keegan, who had been CEO since 2022, will remain on the board of directors at Monroeville, Pennsylvania-based RQM+.
She said she will move from day-to-day operations at RQM+ to focus more on her role as an operating partner at Chicago-based private equity firm Linden Capital Partners.
Formerly known as Regulatory and Quality Solutions, RQM+ has been a portfolio company of Linden Capital Partners since August 2021.
“During Margaret’s tenure, she completed three acquisitions and made significant progress in creating an end-to-end MedTech CRO at RQM+,” Potthoff said in a news release. “I look forward to building on this remarkable foundation and continuing to drive growth and advance global healthcare through MedTech innovation.”
Potthoff is the co-founder and former CEO of Elligo Health Research. He has been on RQM+’s board of directors since 2021. Prior to Elligo, Potthoff was CEO of Theorem Clinical Research and was chief operating officer at INC Research.
Keegan will continue to assist RQM+ on the board to execute its core priorities, according to the company.
“I am extremely proud of the RQM+ team’s many accomplishments,” Keegan said. “While I’ll be stepping away from day-to-day operations, I look forward to continuing to support the company. I believe John is a proven leader and is very knowledgeable about the company and our industry. He is well-positioned to lead and enhance RQM+ to meet the ever-changing MedTech industry needs now and into the future.”
After acquiring Maetrics in 2020 and rebranding itself in 2021, RQM+ said it had become the world’s largest medical device- and diagnostics-focused regulatory and quality consulting company.
